Novel Therapeutic Targets

Autoimmunity results from a break in self-tolerance involving humoral and/or cell-mediated immune mechanisms. One pathological consequence of a failure in central and/or peripheral tolerance is the generation of autoantibodies and subsequent formation of complement-fixing immune complexes that contribute to tissue damage. Prevailing pharmacological strategies for treating autoimmune diseases involve the use of broad-acting immunosuppressants that with long term use have associated toxicities. 

  • Drug Delivery Systems
  • Membrane Proteins/Antagonists & Inhibitors
  • Tumor Necrosis Factor-alpha/Metabolism

Related Conference of Novel Therapeutic Targets

July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
July 29-30, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
November 12-13, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
November 14-15, 2019

International Conference on Vaccines and Immune Response

Istanbul, Turkey
November 14-15, 2019

Annual Congress on Antibiotics and Antimicrobial Resistance

Geneva, Switzerland
November 21-22, 2019

World Conference on Vaccine and Immunology

Dubai, UAE

Novel Therapeutic Targets Conference Speakers

Recommended Sessions

Related Journals

Are you interested in